Skip to main content

Tripos and Elsevier to Integrate Informatics Platforms

NEW YORK, Aug. 10 (GenomeWeb News) - Tripos and Elsevier MDL today said they plan to integrate their informatics platforms.


The two companies will now work to integrate the work-flow capabilities between Elsevier's MDL Isentris technology and Trips' Benchware suite of laboratory informatics software.


Under the terms of the agreement Tripos will now be a strategic member of the MDL Isentris Alliance, and Elsevier MDL will join the Tripos Alliance Program as a global strategic partner, the firms said.


Elsevier MDL CEO Lars Barfod said the alliance would facilitate "the integration of data and workflow between our products -- which is something that customers have been asking for."


Financial details were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.